Volume 58, Issue 1, Pages (July 2010)

Slides:



Advertisements
Similar presentations
Volume 46, Issue 4, Pages (October 2004)
Advertisements

Volume 71, Issue 5, Pages (May 2017)
Volume 64, Issue 5, Pages (November 2013)
Tumor Progression of Skin Carcinoma Cells in Vivo Promoted by Clonal Selection, Mutagenesis, and Autocrine Growth Regulation by Granulocyte Colony-Stimulating.
Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts  Min Yao, Curtis Smart, Qingting.
Enhanced Sensitivity to Sunitinib by Inhibition of Akt1 Expression in Human Castration- resistant Prostate Cancer PC3 Cells Both In Vitro and In Vivo 
The PSA Era is not Over for Prostate Cancer
Volume 68, Issue 2, Pages (August 2015)
Volume 60, Issue 2, Pages (August 2011)
Volume 67, Issue 6, Pages (June 2015)
Alvin Y. Liu, Martine P. Roudier, Lawrence D. True 
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel- Associated Mural Cells  Sven Christian, Renate Winkler, Iris Helfrich,
Volume 72, Issue 5, Pages (November 2017)
Volume 129, Issue 6, Pages (December 2005)
Volume 67, Issue 4, Pages (April 2015)
Volume 60, Issue 2, Pages (August 2011)
Volume 66, Issue 1, Pages (July 2014)
Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the Prostate  K.
Volume 16, Issue 6, Pages (August 2016)
Volume 51, Issue 2, Pages (February 2007)
Testosterone and Prostate Cancer: Revisiting Old Paradigms
Volume 49, Issue 1, Pages (January 2006)
Volume 52, Issue 3, Pages (September 2007)
Volume 55, Issue 4, Pages (April 2009)
Volume 52, Issue 3, Pages (September 2007)
Volume 64, Issue 5, Pages (November 2013)
Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells by Lin Qiu, Raymond Lai, Quan Lin, Esther.
Volume 52, Issue 6, Pages (December 2007)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 71, Issue 1, Pages 1-3 (January 2017)
Volume 43, Issue 4, Pages (April 2003)
CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection
Volume 62, Issue 1, Pages (July 2012)
Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer  Ryo Yuge, Yasuhiko Kitadai,
Volume 60, Issue 5, Pages (November 2011)
Interleukin-17 and Prostaglandin E2 Are Involved in Formation of an M2 Macrophage- Dominant Microenvironment in Lung Cancer  Lunxu Liu, MD, PhD, Dongxia.
The PSA Era is not Over for Prostate Cancer
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Leonard S. Marks, Jiaoti Huang  European Urology 
Volume 67, Issue 6, Pages (June 2015)
Volume 134, Issue 1, Pages (January 2008)
Volume 4, Issue 3, Pages (September 2003)
Volume 43, Issue 2, Pages (February 2003)
Volume 46, Issue 4, Pages (October 2004)
Volume 67, Issue 1, Pages (January 2015)
CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis
Volume 140, Issue 1, Pages e4 (January 2011)
Mammalian Target of Rapamycin Inhibitors in Clinical Practice: Case Reports of Everolimus in Renal Cell Carcinoma  Sergio Bracarda, Alain Ravaud, Marino.
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 71, Issue 5, Pages (May 2017)
Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer  Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.
Intrinsic Patterns of Behavior of Epithelial Stem Cells
Volume 1, Issue 1, Pages (February 2002)
Volume 132, Issue 7, Pages (June 2007)
Volume 52, Issue 6, Pages (December 2007)
Volume 66, Issue 6, Pages (December 2014)
Activin A Is Anti-Lymphangiogenic in a Melanoma Mouse Model
Einar K. Rofstad, Bjørn A. Graff  Journal of Investigative Dermatology 
Volume 117, Issue 7, Pages (June 2004)
HERBERT C. RUCKLE, M. D. , GEORGE G. KLEE, M. D. , PH. D. , JOSEPH E
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Hermine Schlagbauer-Wadl, Marieke Griffioen, Andrea van Elsas, Peter I
Volume 121, Issue 4, Pages (October 2001)
Volume 117, Issue 4, Pages (October 1999)
Volume 68, Issue 2, Pages (August 2015)
Annika Berntsen, Poul F. Geertsen, Inge Marie Svane  European Urology 
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors  Hideyuki Oguro, Lei Ding, Sean J.
Volume 29, Issue 5, Pages (May 2016)
B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma  Jinhua Wang, Kelly K. Chong, Yoshitaka Nakamura, Linhda.
Presentation transcript:

Volume 58, Issue 1, Pages 162-172 (July 2010) Human Prostate Fibroblasts Induce Growth and Confer Castration Resistance and Metastatic Potential in LNCaP Cells  George N. Thalmann, Hong Rhee, Robert A. Sikes, Sen Pathak, Ashi Multani, Haiyen E. Zhau, Fray F. Marshall, Leland W.K. Chung  European Urology  Volume 58, Issue 1, Pages 162-172 (July 2010) DOI: 10.1016/j.eururo.2009.08.026 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 Scheme of the development of the different cell lines. PZ=peripheral zone; TZ=transition zone. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 2 Characteristics of three paired fibroblast cell lines (9922PZ, 9922TZ, 90969PZ, 90969TZ, 55033PZ, 55033TZ) from the transition (TZ) and peripheral zone (PZ) of the prostate of three different patients. (A) Intrinsic in vitro growth curves of paired PZ- and TZ-derived cell lines derived from three patients over 9 d. Culture medium was changed on days 0, 3, and 6. Intrinsic growth of TZ fibroblasts was significantly (p<0.05) faster than that of PZ fibroblasts in two of three patients, although in 9922 fibroblasts the difference was not large. (B) Dihydrotestosterone-induced growth in three PZ and three TZ fibroblast cell lines. TZ fibroblasts show a significantly (p<0.0001) stronger growth induction by 1nM dihydrotestosterone than PZ fibroblasts, expressed as percent over control. (c) In vitro clonogenic assay (soft agar colony formation): Effect of conditioned medium (CM) from three TZ and three PZ fibroblast cell lines on prostatic epithelial (NbE) and lymph node carcinoma of the prostate (LNCaP) cell anchorage-independent growth. PZ CM and TZ CM significantly (p<0.001) induced anchorage-independent growth of NbE and LNCaP cells. Interestingly, LNCaP cells were significantly (p<0.001) more sensitive to PZ CM. SACF=soft agarose colony formation. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 3 Representative panel of tumors injected subcutaneously induced by fibroblasts derived from different zones of the prostate. Histomorphologic analysis of tumors induced by human prostate fibroblasts revealed different morphologic patterns with some variation in tumors induced by different fibroblasts: (A) example of a small glandular growth pattern in the tumor induced by central zone (CZ) fibroblasts; (B) a more solid tumor growth with little stroma with transitional zone (TZ) fibroblasts; and (C) diffuse glandular growth with anaplastic features with peripheral zone (PZ) fibroblasts. Immunohistochemical staining for prostate-specific antigen (PSA) in consecutive sections of a P4-2 tumor. (D) Prostate-specific antigen (PSA) antibody (PSA expression red); (E) staining using isotype-specific immunoglobulin as control. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 4 Representative panel of P4, P4-2, T4, T4-2 tumors and metastases (main image, ×4 magnification; insert ×20 magnification): (a) primary tumor P4, solid invasive growth with hypervascularization; (b) lymph node metastasis P4-2, glandular structures in the lymph node tissue; (c) nodular lung metastasis T4-2, solid; (d) bone metastasis P4-2 spinal column with destruction of cortical bone and periosteal growth of tumor cells. Bone metastases were mostly micrometastatic. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 5 (a) Prostate-specific antigen (PSA) levels (nanograms per milliliter) of parental lymph node carcinoma of the prostate (LNCaP) cells and their derivative P and T sublines in relation to cell density (optical density [OD]: 590nm). *PSA levels significantly increased in T4-2, P4, and P4-2 cells as compared to the parental LNCaP cell line (p<0.05). (b) Intrinsic in vitro growth of LNCaP sublines as compared to the parental LNCaP cell line. Intrinsic growth rates increased with increased androgen-independence. (c) Clonogenic growth (soft agar colony formation assay) of LNCaP sublines as compared to the parental LNCaP cell line. Cell lines derived from the peripheral zone had a significant stronger anchorage-independent growth. SACF=soft agarose colony formation. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 6 (a) G-banded karyotype of the parental lymph node carcinoma of the prostate (LNCaP) cell line. (b–e) Typical G-banded karyotypes and both types of marker chromosomes (M and m series) from (b) T4; (c) T 4-2; (d) P4; and (e) P4-2 cell lines, respectively. All cell lines are of human origin and have maintained marker chromosomes (M1-7) of the parental LNCaP cell line. Chromosome numbers range from 65 to 90 in all the four clones with a modal number of 88 for T4, 87 for T4-2, 83 for P4, and 90 for P4-2. Among the new markers (m1-6), only m4 and m6 are shared by all four cell lines; m3 is present only in P4-2 and T4-2; m5 is present in both P4 and P4-2 but is absent in T4 and T4-2. (f) Summary of old and new markers in the different cell lines. All marker chromosomes were identified based on their characteristic G-banding patterns and found to be clonal since they were present in more than two metaphases. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 6 (a) G-banded karyotype of the parental lymph node carcinoma of the prostate (LNCaP) cell line. (b–e) Typical G-banded karyotypes and both types of marker chromosomes (M and m series) from (b) T4; (c) T 4-2; (d) P4; and (e) P4-2 cell lines, respectively. All cell lines are of human origin and have maintained marker chromosomes (M1-7) of the parental LNCaP cell line. Chromosome numbers range from 65 to 90 in all the four clones with a modal number of 88 for T4, 87 for T4-2, 83 for P4, and 90 for P4-2. Among the new markers (m1-6), only m4 and m6 are shared by all four cell lines; m3 is present only in P4-2 and T4-2; m5 is present in both P4 and P4-2 but is absent in T4 and T4-2. (f) Summary of old and new markers in the different cell lines. All marker chromosomes were identified based on their characteristic G-banding patterns and found to be clonal since they were present in more than two metaphases. European Urology 2010 58, 162-172DOI: (10.1016/j.eururo.2009.08.026) Copyright © 2009 European Association of Urology Terms and Conditions